BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries North America

Sentia Medical Sciences and Neurocrine Biosciences Extend Research Collaboration to Discover Novel CRF Peptides

The collaboration will continue to leverage Sentia’s proprietary peptide-based platform and Neurocrine’s drug development expertise in CR...

February 15, 2023 | News

AnPac Bio-Medical Science Expand Scope of Business in the U.S.

AnPac Bio-Medical Science Co., Ltd. (the "Company") (NASDAQ: ANPC), a company with operations in the United States and China announced ...

February 14, 2023 | News

U.S. Government and Novavax Extend Partnership

Modified agreement also includes the development of an updated vaccine in fall 2023 Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to...

February 14, 2023 | News

MedHQ Partners with Avanza Healthcare Strategies

MedHQ, a leading provider of technology-enabled expert services including human resources, staffing, and financial management to outpatient healthcar...

February 10, 2023 | News

U.S. Centers for Disease Control to extend National Wastewater Surveillance System contract with Biobot Analytics

As part of NWSS, Biobot contributes data from more than 400 locations from over 250 counties across a total of 50 states and U.S. Territories, providing co...

February 09, 2023 | News

Parse Biosciences Announces Evercode TCR and Gene Capture

Parse Biosciences, a leading provider of accessible and scalable single-cell sequencing solutions, today announced the availability of Evercode&trade...

February 08, 2023 | News

Recce Pharmaceuticals Announces RECCE® Trademark Registered in Hong Kong

Recce Pharmaceuticals Ltd (ASX: RCE, FSE: R9Q) (the Company), the Company developing a new class of synthetic anti-infectives, today announced that it has ...

February 03, 2023 | News

Magenta Therapeutics to Explore Strategic Alternatives

As part of this review process, Magenta will explore potential strategic alternatives that may include, but are not limited to, an acquisition, merger, bus...

February 03, 2023 | News

Superstratum and AirAnswers® Team-Up in the Fight Against Sick Building Syndrome

Both companies join forces to identify and alleviate indoor mycotoxins and molds that can contribute to symptoms associated with sick building syndrome. Si...

February 02, 2023 | News

Amjevita™ (Adalimumab-atto), First Biosimilar to Humira®, Now Available in the United States

Amgen (NASDAQ:AMGN) announced AMJEVITA™ (adalimumab-atto), a biosimilar to Humira®* (adalimumab), is now available in the Un...

February 01, 2023 | News

Dr. Reddy's Laboratories announces the launch of Difluprednate Ophthalmic Emulsion 0.05%

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY, along with its subsidiaries together referred to as “Dr....

January 30, 2023 | News

Dr. Reddy’s successfully completes full set of clinical studies of its rituximab biosimilar for filing in the U.S., Europe

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; hereafter referred to as “Dr. Reddy’s”), a g...

January 23, 2023 | News

Summit Therapeutics Closes Deal with Akeso Inc. to In-License Breakthrough Innovative Bispecific Antibody

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that we have completed the c...

January 23, 2023 | News

Speakers Announced for 2023 BIO CEO & Investor Conference

The Biotechnology Innovation Organization (BIO) will hold its CEO & Investor Conference February 6-9, 2023 to bring biotech companies togethe...

January 18, 2023 | News

Stay Connected